Skip to content

The influence of low-energy red light on myopic visual function and choroidal-retinal structure and blood supply

The influence of low-energy red light on myopic visual function and choroidal-retinal structure and blood supply

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600116949
Enrollment
Unknown
Registered
2026-01-16
Start date
2025-09-24
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Interventions

Emmetropia/Low Myopia Group:Provide red light therapy to the red LED lighting device for 1 month, twice a day, 3 minutes each time, with more than 4 hours between sessions. The maximum brightness of t
High myopia group:Provide red light therapy to the red LED lighting device for 1 month, twice a day, 3 minutes each time, with more than 4 hours between sessions. The maximum brightness of this LED de
Moderate myopia group:Provide red light therapy to the red LED lighting device for 1 month, twice a day, 3 minutes each time, with more than 4 hours between sessions. The maximum brightness of this LE

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 30 Years

Inclusion criteria

Inclusion criteria: 1.Aged between 18 and 30 years old; 2.Based on subjective refraction results: Spherical equivalent (SE) <= +0.50 diopters (D); Astigmatism <= 1.50 diopters (D); Anisometropia <= 1.50 diopters (D).

Exclusion criteria

Exclusion criteria: 1.At risk of glaucoma, including shallow anterior chamber (peripheral depth 21 mmHg); 2.Severe opacity of refractive media (e.g., cornea, lens), which impairs imaging quality; 3.A history of any surgery other than refractive correction surgery; 4.Presence of fundus lesions, including choroidal neovascularization (CNV), macular retinoschisis, etc.; 5.Suffering from severe systemic diseases, or having no independent behavioral and cognitive abilities; 6.Poor compliance, unable to complete the entire trial.

Design outcomes

Primary

MeasureTime frame
Rapid Sensitivity Comparison;

Secondary

MeasureTime frame
Microperimetry;Choroidal thickness;Retinal structure;

Countries

China

Contacts

Public ContactShao Yilei

Eye Hospital, Wenzhou Medical University

shaoyl1986@wmu.edu.cn+86 136 7673 6350

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026